Home | Screening data | Screen comparisons | Search for compounds | Structure search

Compound InformationSONAR Target prediction
Name:

ISOPROTERENOL HYDROCHLORIDE

Unique Identifier:SPE01500357
MolClass: Checkout models in ver1.5 and ver1.0
Molecular Formula:
Molecular Weight:229.575 g/mol
X log p:6.284  (online calculus)
Lipinksi Failures1
TPSA0
Hydrogen Bond Donor Count:0
Hydrogen Bond Acceptors Count:4
Rotatable Bond Count:4
Canonical Smiles:Cl.CC(C)NCC(O)c1ccc(O)c(O)c1
Source:synthetic
Therapeutics:bronchodilator
Generic_name:Isoproterenol
Chemical_iupac_name:4-[1-hydroxy-2-(1-methylethylamino)ethyl]benzene-1,2-diol
Drug_type:Approved Drug
Pharmgkb_id:PA450121
Kegg_compound_id:C07056
Drugbank_id:APRD00182
Melting_point:170.5 oC
Logp:1.172
Cas_registry_number:7683-59-2
Mass_spectrum:http://webbook.nist.gov/cgi/cbook.cgi?Spec=C7683592&Index=0&Type=Mass&Large=on
Drug_category:Cardiotonic Agents; Bronchodilator Agents; Sympathomimetic; ATC:R03AC
Indication:For the treatment of mild or transient episodes of heart block that do not require
electric shock or pacemaker therapy also used in management of asthma and chronic
bronchitis
Pharmacology:Isoproterenol is a relatively selective beta2-adrenergic bronchodilator.
Isoproterenol is indicated for the relief of bronchospasm associated with chronic
obstructive pulmonary disease. The pharmacologic effects of beta adrenergic agonist
drugs, including Isoproterenol, are at least in part attributable to stimulation
through beta adrenergic receptors of intracellular adenyl cyclase, the enzyme which
catalyzes the conversion of adenosine triphosphate (ATP) to cyclic- 3-,5-- adenosine
monophosphate (c-AMP). Increased c-AMP levels are associated with relaxation of
bronchial smooth muscle and inhibition of release of mediators of immediate
hypersensitivity from cells, especially from mast cells.
Mechanism_of_action:The pharmacologic effects of Isoproterenol are at least in part attributable to
stimulation through beta-adrenergic receptors of intracellular adenyl cyclase, the
enzyme that catalyzes the conversion of adenosine triphosphate (ATP) to cyclic AMP.
Increased cyclic AMP levels are associated with relaxation of bronchial smooth
muscle and inhibition of release of mediators of immediate hypersensitivity from
cells, especially from mast cells.
Organisms_affected:Humans and other mammals

Found: 205 nonactive as graph: single | with analogs [1] << Back 1 2 3 4 5 6 7 8 9 10  Next >> [205]
Species: 4932
Condition: BY4741-2nd
Replicates: 2
Raw OD Value: r im 0.9090±0.00388909
Normalized OD Score: sc h 0.9824±0.00452574
Z-Score: 0.4141±0.16438
p-Value: 0.680814
Z-Factor: -2.66413
Fitness Defect: 0.3845
Bioactivity Statement: Nonactive
Experimental Conditions
Library:Spectrum_ED
Plate Number and Position:3|E5
Drug Concentration:50.00 nM
OD Absorbance:595 nm
Robot Temperature:30.00 Celcius
Date:2012-05-28 YYYY-MM-DD
Plate CH Control (+):0.09799999999999999±0.00719
Plate DMSO Control (-):0.9354999999999999±0.04170
Plate Z-Factor:0.8249
png
ps
pdf

DBLink | Rows returned: 11<< Back 1 2
656783 4-[(1R)-1-hydroxy-2-(propan-2-ylamino)ethyl]benzene-1,2-diol hydrochloride
3931172 [2-(3,4-dihydroxyphenyl)-2-hydroxy-ethyl]-propan-2-yl-azanium
3987759 4-[1-hydroxy-2-(propan-2-ylamino)ethyl]benzene-1,2-diol; platinum
6921599 [(2R)-2-(3,4-dihydroxyphenyl)-2-hydroxy-ethyl]-propan-2-yl-azanium
6921600 [(2S)-2-(3,4-dihydroxyphenyl)-2-hydroxy-ethyl]-propan-2-yl-azanium

internal high similarity DBLink | Rows returned: 5
JFD 01582 0.9016
SPE01500390 0.9016
LOPAC 00895 0.9167
LOPAC 00121 1.0000
LOPAC 00984 1.0000

active | Cluster 1040 | Additional Members: 10 | Rows returned: 1
LOPAC 00113 0

Service provided by the Mike Tyers Laboratory